[Federal Register: April 22, 2004 (Volume 69, Number 78)]
[Notices]               
[Page 21837-21838]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr22ap04-65]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

 
A Public Health Action Plan To Combat Antimicrobial Resistance 
(Part I: Domestic Issues): Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report

    The Centers for Disease Control and Prevention (CDC), Food and Drug 
Administration (FDA), and National Institutes of Health (NIH) announce 
an open meeting concerning antimicrobial resistance.

    Name: A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues): Meeting for Public Comment on 
the Antimicrobial Resistance Interagency Task Force Annual Report.
    Time and Date: 1:30 p.m.-5 p.m., June 30, 2004.
    Place: Hyatt Regency Bethesda, Waterford/Lalique Suite, One 
Bethesda Metro Center, 7400 Wisconsin Avenue at Old Georgetown Road, 
Bethesda, Maryland, 20814; telephone: 1-301-657-1234; Fax: 1-301-
657-6453.
    Status: Open to the public, limited only by the space available.
    Purpose: To present the third annual report of progress by 
Federal agencies in accomplishing activities outlined in A Public 
Health Action Plan to Combat Antimicrobial Resistance (Part I: 
Domestic Issues), and solicit comments from the public regarding the 
annual report. The Action Plan serves as a blueprint for activities 
of Federal agencies to address antimicrobial resistance. The focus 
of the plan is on domestic issues.
    Matters to be Discussed: The agenda will consist of welcome, 
introductory comments, followed by discussion of four focus areas in 
sequential plenary sessions lasting up to 45 minutes each. The four 
focus areas are: Surveillance, Prevention and Control, Research, and 
Product Development. Session leaders will give a 10 to 15 minute 
overview at the beginning of each session, then open the meeting for 
general discussion.
    Comments and suggestions from the public for Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsements of specific commercial products.
    The Action Plan, Annual Report, and meeting agenda will be 
available at http://www.cdc.gov/drugresistance. The public meeting 

is sponsored by the CDC, FDA, and NIH, in collaboration with seven 
other Federal agencies and departments involved in developing and 
writing A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues).
    Agenda items are subject to change as priorities dictate.
    Limited time will be available for oral questions, comments, and 
suggestions from the public. Depending on the number wishing to 
comment, a time limit of three minutes may be imposed. In the 
interest of time, visual aids will not be permitted, although 
written material may be submitted to the Task Force. Written 
comments and suggestions from the public are encouraged and can be 
submitted at the meeting or should be received by the contact person 
by regular mail or email listed below no later than July 31, 2004.
    Persons anticipating attending the meeting are requested to send 
written notification to the contact person below by June 18, 2004, 
including name, organization (if applicable), address, phone, fax, 
and e-mail address.
    For Further Information Contact: Ms. Vickie Garrett, 
Antimicrobial Resistance, Office of the Director, NCID, CDC, mail 
stop C-12, 1600 Clifton Road, NE, Atlanta, Georgia 30333; telephone 
404-639-2603; fax 404-639-4197; or e-mail aractionplan@cdc.gov.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for

[[Page 21838]]

CDC and the Agency for Toxic Substances and Disease Registry.

    Dated: April 15, 2004.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-9103 Filed 4-21-04; 8:45 am]

BILLING CODE 4163-18-P